Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hubbard

Showing results (171-180 of 258) with videos related to

Pageof 26
Sort By:
British Journal of Clinical Pharmacology|August 1, 1981
Radioimmunoassay for trifluoperazine in human plasmaK K Midha, J W Hubbard, J K Cooper, et al.
Aviation, Space, and Environmental Medicine|May 1, 1992
Fluid-electrolyte losses in uniforms during prolonged exercise at 30 degrees CL E Armstrong, P C Szlyk, J P De Luca, et al.
Journal of the American College of Cardiology|July 1, 1994
Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable anginaD Holdright, D Patel, D Cunningham, et al.
Therapeutic Drug Monitoring|January 1, 1986
Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human bloodE M Hawes, J W Hubbard, M Martin, et al.
Archivos Latinoamericanos De Nutricion|June 1, 1988
Separate effects of dietary protein and fat on serum cholesterol levels: another view of amino acid content of proteinsA Sánchez, D A Rubano, G W Shavlik, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failureJ Wang, G Zhao, W Shen, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Comparative bioavailability of a new commercial tablet formulation and two lots of a reference formulation of haloperidolK K Midha, B S Chakraborty, R Schwede, et al.
Pacing and Clinical Electrophysiology : PACE|February 1, 1991
Natural history of sinus node chronotropy in paced patientsP E Vardas, A Fitzpatrick, A Ingram, et al.
Therapeutic Drug Monitoring|January 1, 1985
Therapeutic monitoring of chlorpromazine II: Pitfalls in whole blood analysisG McKay, J K Cooper, E M Hawes, et al.
Studies in Health Technology and Informatics|March 23, 2007
Medical student evaluation using augmented standardized patients: new development and resultsBo Sun, Frederic D McKenzie, Hector M Garcia, et al.
Pageof 26

Showing results (171-180 of 258) with videos related to

Sort By:
Pageof 26
British Journal of Clinical Pharmacology|August 1, 1981
Radioimmunoassay for trifluoperazine in human plasmaK K Midha, J W Hubbard, J K Cooper, et al.
Aviation, Space, and Environmental Medicine|May 1, 1992
Fluid-electrolyte losses in uniforms during prolonged exercise at 30 degrees CL E Armstrong, P C Szlyk, J P De Luca, et al.
Journal of the American College of Cardiology|July 1, 1994
Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable anginaD Holdright, D Patel, D Cunningham, et al.
Therapeutic Drug Monitoring|January 1, 1986
Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human bloodE M Hawes, J W Hubbard, M Martin, et al.
Archivos Latinoamericanos De Nutricion|June 1, 1988
Separate effects of dietary protein and fat on serum cholesterol levels: another view of amino acid content of proteinsA Sánchez, D A Rubano, G W Shavlik, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failureJ Wang, G Zhao, W Shen, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Comparative bioavailability of a new commercial tablet formulation and two lots of a reference formulation of haloperidolK K Midha, B S Chakraborty, R Schwede, et al.
Pacing and Clinical Electrophysiology : PACE|February 1, 1991
Natural history of sinus node chronotropy in paced patientsP E Vardas, A Fitzpatrick, A Ingram, et al.
Therapeutic Drug Monitoring|January 1, 1985
Therapeutic monitoring of chlorpromazine II: Pitfalls in whole blood analysisG McKay, J K Cooper, E M Hawes, et al.
Studies in Health Technology and Informatics|March 23, 2007
Medical student evaluation using augmented standardized patients: new development and resultsBo Sun, Frederic D McKenzie, Hector M Garcia, et al.
Pageof 26